Detalles de la búsqueda
1.
Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.
Graefes Arch Clin Exp Ophthalmol
; 255(1): 77-87, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27460280
2.
Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
Graefes Arch Clin Exp Ophthalmol
; 254(12): 2307-2318, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27286894
3.
Efficacy and Safety of Botulinum Toxin Type A for the Prevention of Postoperative Atrial Fibrillation.
JACC Clin Electrophysiol
; 10(5): 930-940, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38661602
4.
Erratum to: Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.
Graefes Arch Clin Exp Ophthalmol
; 255(1): 89, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27957602
5.
A 12-month, multicenter, parallel group comparison of dexamethasone intravitreal implant versus ranibizumab in branch retinal vein occlusion.
Eur J Ophthalmol
; 28(6): 697-705, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29631435
6.
Preservative-free bimatoprost 0.03% in patients with primary open-angle glaucoma or ocular hypertension in clinical practice.
Clin Ophthalmol
; 10: 1759-65, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27672307
7.
A prospective, multicenter, noninterventional study of Optive Plus(®) in the treatment of patients with dry eye: the prolipid study.
Clin Ophthalmol
; 8: 1147-55, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24970993
Resultados
1 -
7
de 7
1
Próxima >
>>